These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 334223)

  • 1. Nomifensine in Parkinson's disease.
    Bedard P; Parkes JD; Marsden CD
    Br J Clin Pharmacol; 1977; 4Suppl 2(Suppl 2):187S-190S. PubMed ID: 334223
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nomifensine in parkinsonism.
    Park DM; Findley LJ; Teychenne PF
    Br J Clin Pharmacol; 1977; 4Suppl 2(Suppl 2):185S-186S. PubMed ID: 334222
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nomifensine: effect in Parkinsonian patients not receiving levodopa.
    Park DM; Findley LJ; Hanks G; Sandler M
    J Neurol Neurosurg Psychiatry; 1981 Apr; 44(4):352-4. PubMed ID: 7241163
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A review of controlled studies with nomifensine, performed outside the UK.
    Habermann W
    Br J Clin Pharmacol; 1977; 4Suppl 2(Suppl 2):237S-241S. PubMed ID: 334230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An overview of side effects and long-term experience with nomifensine from United States clinical trials.
    Yakabow AL; Hardiman S; Nash RJ
    J Clin Psychiatry; 1984 Apr; 45(4 Pt 2):96-101. PubMed ID: 6370985
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does levodopa slow or hasten the rate of progression of Parkinson's disease?
    Fahn S;
    J Neurol; 2005 Oct; 252 Suppl 4():IV37-IV42. PubMed ID: 16222436
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A controlled study comparing trihexyphenidyl hydrochloride plus levodopa with placebo plus levodopa in patients with Parkinson's disease.
    Martin WE; Loewenson RB; Resch JA; Baker AB
    Neurology; 1974 Oct; 24(10):912-9. PubMed ID: 4606107
    [No Abstract]   [Full Text] [Related]  

  • 8. Dopaminergic agonist nomifensine compared with amitriptyline: a double-blind clinical trial in acute primary depressions.
    Grof P; Saxena B; Daigle L; Mahutte G
    Br J Clin Pharmacol; 1977; 4Suppl 2(Suppl 2):221S-225S. PubMed ID: 334227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Levodopa and the progression of Parkinson's disease.
    Fahn S; Oakes D; Shoulson I; Kieburtz K; Rudolph A; Lang A; Olanow CW; Tanner C; Marek K;
    N Engl J Med; 2004 Dec; 351(24):2498-508. PubMed ID: 15590952
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A double-blind comparison of nomifensine and amitriptyline in the treatment of depression.
    Ong SB; Lee CT
    Acta Psychiatr Scand; 1981 Mar; 63(3):198-207. PubMed ID: 7015790
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multicenter placebo-controlled evaluation of nomifensine treatment in depressed outpatients.
    Feighner JP; Merideth CH; Claghorn JL
    J Clin Psychiatry; 1984 Apr; 45(4 Pt 2):47-51. PubMed ID: 6370974
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Controlled clinical trial of nomifensine, a non tricyclic antidepressant drug.
    De Maio D; Nielsen NP; Sesso M; Griner A
    Acta Neurol (Napoli); 1978; 33(3):230-42. PubMed ID: 371350
    [No Abstract]   [Full Text] [Related]  

  • 13. A double-blind comparative evaluation of the efficacy and safety of nomifensine, imipramine, and placebo in depressed geriatric outpatients.
    Merideth CH; Feighner JP; Hendrickson G
    J Clin Psychiatry; 1984 Apr; 45(4 Pt 2):73-7. PubMed ID: 6370981
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nomifensine in geriatric inpatients: a placebo-controlled study.
    Jansen W; Siegfried K
    J Clin Psychiatry; 1984 Apr; 45(4 Pt 2):63-7. PubMed ID: 6370979
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Controlled randomized group comparison of nomifensine and imipramine in depressive illness.
    Forrest A; Hewett A; Nicholson P
    Br J Clin Pharmacol; 1977; 4Suppl 2(Suppl 2):215S-220S. PubMed ID: 334226
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contrasts in antidepressant medications.
    Wittenborn JR
    Br J Clin Pharmacol; 1977; 4Suppl 2(Suppl 2):153S-156S. PubMed ID: 334218
    [No Abstract]   [Full Text] [Related]  

  • 17. A two-center double-blind study of nomifensine, imipramine, and placebo in depressed geriatric outpatients.
    Cohn JB; Varga L; Lyford A
    J Clin Psychiatry; 1984 Apr; 45(4 Pt 2):68-72. PubMed ID: 6370980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dopaminergic agonist Ro 8-4650 in Parkinson's disease. I. Patients treated with dopa.
    Birket-Smith E; Bøttcher J; Dupont E; Holm P; Jensen JP; Kristensen O; Køhler O; Mikkelsen B
    Acta Neurol Scand; 1978 Jul; 58(1):74-6. PubMed ID: 360759
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Nomifensine: clinical data (author's transl)].
    Clerc G; Cayreyre M
    Nouv Presse Med; 1978 Jun; 7(26):2295-304. PubMed ID: 353720
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Double-blind comparison of the efficacy and safety of nomifensine maleate vs. placebo in depressed outpatients.
    Georgia EH
    J Clin Psychiatry; 1984 Apr; 45(4 Pt 2):43-6. PubMed ID: 6232263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.